Post-authorization clinical trials
The article describes post-authorization clinical trials of medicinal products for medical use conducted by pharmaceutical manufacturers after state registration, in order to collect additional data on safety and efficacy, expand indications for use, and identify adverse reactions.
Main Author: | D. Yu. Belousov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-05-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/74 |
Similar Items
-
Pharmacovigilance system in Eurasian Economic Union
by: I. L. Asetskaya, et al.
Published: (2019-04-01) -
Review of real-world data study
by: T. A. Goldina, et al.
Published: (2021-04-01) -
Аудит клинического исследования
Published: (2018-06-01) -
Мониторинг клинического исследования
Published: (2018-06-01) -
Non-interventional studies
by: D. Yu. Belousov
Published: (2018-05-01)